CCO Oncology Podcast
A podcast by Clinical Care Options
189 Episoade
-
Rationale for NTRK Testing in Patients With Cancer
Publicat: 08.10.2021 -
Expert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate Cancer
Publicat: 07.10.2021 -
Expert Insight on Important Clinical Trial Data From ESMO 2021 Informing Treatment for Endometrial and Ovarian Cancer
Publicat: 29.09.2021 -
Expert Insight on New Evidence Poised to Change the Treatment Landscape in Melanoma
Publicat: 28.09.2021 -
Expert Insight on Practice Changing From IGCS 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer
Publicat: 21.09.2021 -
Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs
Publicat: 24.08.2021 -
Expert Insights on Optimal Use of CDK4/6 Inhibitors for HR-Positive/HER2-Negative Breast Cancer
Publicat: 19.08.2021 -
Essential Biomarker Testing in GI Cancers
Publicat: 18.08.2021 -
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Expert Answers to Clinician Questions
Publicat: 05.08.2021 -
The Latest Advances and Guidance in Nonmetastatic Castration-Resistant Prostate Cancer
Publicat: 30.07.2021 -
Managing Serious Adverse Events Associated with BTK Inhibitor Treatment
Publicat: 27.07.2021 -
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 2: Patient Strategies for Self-Management
Publicat: 27.07.2021 -
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions
Publicat: 27.07.2021 -
BTK Inhibitors in CLL and Lymphomas: Overview and Current Indications
Publicat: 23.07.2021 -
Adverse Events Associated with BTK Inhibitor Treatment
Publicat: 23.07.2021 -
Radiopharmaceuticals in the Treatment of Metastatic Castration-Resistant Prostate Cancer
Publicat: 20.07.2021 -
How to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on BCMA-Targeted Therapies
Publicat: 19.07.2021 -
Expert Answers to HCP Questions on CAR T-Cell Therapy
Publicat: 19.07.2021 -
How to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on Selinexor, Venetoclax, and Melphalan Flufenamide
Publicat: 16.07.2021 -
Caring for Patients With Newly Diagnosed Multiple Myeloma
Publicat: 14.07.2021
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
